title: Systemic expression of cutaneous basophil hypersensitivity.
abstract: Guinea pigs primed for cutaneous basophil hypersensitivity (CBH) with several soluble proteins or with sheep erythrocytes developed a systemic, delayed-onset, maculopapular rash when challenged parenterally with specific antigen. The rash was most readily induced 5 to 7 days after immunization, at a time when local CBH skin test reactivity was also optimal. Miscroscopically, the rash resembled local CBH skin test reactions, being comprised of a papillary dermal infiltrate of basophils and lymphocytes and a striking dilatation and compaction of superficial venules. In addition to the systemic rash, animals expressing systemic CBH (SCBH) exhibited a striking eosinophilia at 24 hr which gave way to basophilia at 48 hr. Focal collections of eosinophils, and of smaller numbers of basophils, were found in the lungs and spleen; both eosinophils and basophils infiltrated the medulla of the thymus. Thus, basophil-rich infiltrations are favored in the skin even after systemic challenge with antigen and occur only to a much smaller extent in other organs where eosinophils may predominate. These differences in the response of various organs to challenge with parenteral antigen suggest that as yet unidentified local factors play a determinative role in regulating the inflammatory response. The pathogenesis of SCBH is not yet established, but it shares many of the properties of local CBH: histology, carrier specificity, development early after sensitization in the absence of detectable antibodies. Passive transfer has not been accomplished with serum alone but has been achieved irregularly with cells plus serum. SCBH may serve as a useful model for several disease states in man characterized by a systemic rash and eosinophilia, including certain types of drug reaction.
mesh_terms: D000818:Animals; D000941:Antigens / Q000008:administration & dosage; D001491:Basophils / Q000276:immunology*; D003877:Dermatitis, Contact / Q000276:immunology / Q000473:pathology; D004802:Eosinophilia / Q000276:immunology / Q000473:pathology; D000939:Epitopes; D004912:Erythrocytes / Q000276:immunology; D005260:Female; D005337:Fibrin / Q000276:immunology; D005340:Fibrinogen / Q000276:immunology; D006168:Guinea Pigs; D006968:Hypersensitivity, Delayed / Q000276:immunology* / Q000473:pathology; D007111:Immunity, Cellular; D007116:Immunization, Passive; D008222:Lymphokines / Q000494:pharmacology; D008297:Male; D008934:Mitogens / Q000494:pharmacology; D012867:Skin / Q000276:immunology* / Q000473:pathology; D013997:Time Factors
chemical_list: D000941:Antigens; D000939:Epitopes; D008222:Lymphokines; D008934:Mitogens; D005337:Fibrin; D005340:Fibrinogen